Glucose measurements with sensors and ultrasound

Seungjun Lee, Vivekanand Nayak, Jeffery Dodds, Michael Pishko, Nadine Barrie Smith

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Accurate monitoring of the blood glucose level in diabetics is essential in preventing complications. Generally, conventional over-the-counter glucose meters require frequent painful finger punctures to obtain samples, which makes a noninvasive method preferable. The purpose of this study was to demonstrate that glucose levels can be measured transdermally with the combination of the low-profile cymbal array and an electrochemical glucose sensor consisting of amperometric electrodes and a novel glucose oxidase hydrogel. Interstitial fluid glucose concentrations can be determined with the electrochemical glucose sensor after the skin is made permeable to glucose by ultrasound (US) (20 kHz) with the thin (< 7 mm) and light (< 22 g) cymbal array. Using this array to deliver insulin into hyperglycemic rats, our previous experiments demonstrated that blood glucose levels would decrease 233.3 mg/dl with 5 min of US exposure. With the sensor and array, our goal was to determine the glucose levels of hyperglycemic rats noninvasively and evaluate the possible bioeffects. A total of 12 anesthetized rats were placed into two groups (US exposure group and control group) and the array (ISPTP = 100 mW/cm2) with a saline reservoir operating for 20 min was affixed to the abdomen. The array was removed and an electrochemical glucose sensor was placed on the exposed area to determine the glucose concentrations through the skin. Comparison was made using a commercial glucose meter with the blood collected from a jugular vein. The average blood glucose level determined by the sensor was 356.0 ± 116.6 mg/dl, and the glucose level measured by the commercial glucose meter was 424.8 ± 59.1 mg/dl. These results supported the use of this novel system consisting of the electrochemical glucose sensor and the cymbal array for glucose monitoring.

Original languageEnglish (US)
Pages (from-to)971-977
Number of pages7
JournalUltrasound in Medicine and Biology
Volume31
Issue number7
DOIs
StatePublished - Jul 1 2005

Fingerprint

glucose
Glucose
sensors
blood
Blood Glucose
rats
Glucose Oxidase
Skin
Hydrogel
Extracellular Fluid
Jugular Veins
Punctures
abdomen
insulin
Abdomen
Fingers
oxidase
Electrodes
veins
Insulin

All Science Journal Classification (ASJC) codes

  • Radiological and Ultrasound Technology
  • Biophysics
  • Acoustics and Ultrasonics

Cite this

Lee, Seungjun ; Nayak, Vivekanand ; Dodds, Jeffery ; Pishko, Michael ; Smith, Nadine Barrie. / Glucose measurements with sensors and ultrasound. In: Ultrasound in Medicine and Biology. 2005 ; Vol. 31, No. 7. pp. 971-977.
@article{282280f1d2394f7e86894fb71aff5ea4,
title = "Glucose measurements with sensors and ultrasound",
abstract = "Accurate monitoring of the blood glucose level in diabetics is essential in preventing complications. Generally, conventional over-the-counter glucose meters require frequent painful finger punctures to obtain samples, which makes a noninvasive method preferable. The purpose of this study was to demonstrate that glucose levels can be measured transdermally with the combination of the low-profile cymbal array and an electrochemical glucose sensor consisting of amperometric electrodes and a novel glucose oxidase hydrogel. Interstitial fluid glucose concentrations can be determined with the electrochemical glucose sensor after the skin is made permeable to glucose by ultrasound (US) (20 kHz) with the thin (< 7 mm) and light (< 22 g) cymbal array. Using this array to deliver insulin into hyperglycemic rats, our previous experiments demonstrated that blood glucose levels would decrease 233.3 mg/dl with 5 min of US exposure. With the sensor and array, our goal was to determine the glucose levels of hyperglycemic rats noninvasively and evaluate the possible bioeffects. A total of 12 anesthetized rats were placed into two groups (US exposure group and control group) and the array (ISPTP = 100 mW/cm2) with a saline reservoir operating for 20 min was affixed to the abdomen. The array was removed and an electrochemical glucose sensor was placed on the exposed area to determine the glucose concentrations through the skin. Comparison was made using a commercial glucose meter with the blood collected from a jugular vein. The average blood glucose level determined by the sensor was 356.0 ± 116.6 mg/dl, and the glucose level measured by the commercial glucose meter was 424.8 ± 59.1 mg/dl. These results supported the use of this novel system consisting of the electrochemical glucose sensor and the cymbal array for glucose monitoring.",
author = "Seungjun Lee and Vivekanand Nayak and Jeffery Dodds and Michael Pishko and Smith, {Nadine Barrie}",
year = "2005",
month = "7",
day = "1",
doi = "10.1016/j.ultrasmedbio.2005.04.004",
language = "English (US)",
volume = "31",
pages = "971--977",
journal = "Ultrasound in Medicine and Biology",
issn = "0301-5629",
publisher = "Elsevier USA",
number = "7",

}

Glucose measurements with sensors and ultrasound. / Lee, Seungjun; Nayak, Vivekanand; Dodds, Jeffery; Pishko, Michael; Smith, Nadine Barrie.

In: Ultrasound in Medicine and Biology, Vol. 31, No. 7, 01.07.2005, p. 971-977.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Glucose measurements with sensors and ultrasound

AU - Lee, Seungjun

AU - Nayak, Vivekanand

AU - Dodds, Jeffery

AU - Pishko, Michael

AU - Smith, Nadine Barrie

PY - 2005/7/1

Y1 - 2005/7/1

N2 - Accurate monitoring of the blood glucose level in diabetics is essential in preventing complications. Generally, conventional over-the-counter glucose meters require frequent painful finger punctures to obtain samples, which makes a noninvasive method preferable. The purpose of this study was to demonstrate that glucose levels can be measured transdermally with the combination of the low-profile cymbal array and an electrochemical glucose sensor consisting of amperometric electrodes and a novel glucose oxidase hydrogel. Interstitial fluid glucose concentrations can be determined with the electrochemical glucose sensor after the skin is made permeable to glucose by ultrasound (US) (20 kHz) with the thin (< 7 mm) and light (< 22 g) cymbal array. Using this array to deliver insulin into hyperglycemic rats, our previous experiments demonstrated that blood glucose levels would decrease 233.3 mg/dl with 5 min of US exposure. With the sensor and array, our goal was to determine the glucose levels of hyperglycemic rats noninvasively and evaluate the possible bioeffects. A total of 12 anesthetized rats were placed into two groups (US exposure group and control group) and the array (ISPTP = 100 mW/cm2) with a saline reservoir operating for 20 min was affixed to the abdomen. The array was removed and an electrochemical glucose sensor was placed on the exposed area to determine the glucose concentrations through the skin. Comparison was made using a commercial glucose meter with the blood collected from a jugular vein. The average blood glucose level determined by the sensor was 356.0 ± 116.6 mg/dl, and the glucose level measured by the commercial glucose meter was 424.8 ± 59.1 mg/dl. These results supported the use of this novel system consisting of the electrochemical glucose sensor and the cymbal array for glucose monitoring.

AB - Accurate monitoring of the blood glucose level in diabetics is essential in preventing complications. Generally, conventional over-the-counter glucose meters require frequent painful finger punctures to obtain samples, which makes a noninvasive method preferable. The purpose of this study was to demonstrate that glucose levels can be measured transdermally with the combination of the low-profile cymbal array and an electrochemical glucose sensor consisting of amperometric electrodes and a novel glucose oxidase hydrogel. Interstitial fluid glucose concentrations can be determined with the electrochemical glucose sensor after the skin is made permeable to glucose by ultrasound (US) (20 kHz) with the thin (< 7 mm) and light (< 22 g) cymbal array. Using this array to deliver insulin into hyperglycemic rats, our previous experiments demonstrated that blood glucose levels would decrease 233.3 mg/dl with 5 min of US exposure. With the sensor and array, our goal was to determine the glucose levels of hyperglycemic rats noninvasively and evaluate the possible bioeffects. A total of 12 anesthetized rats were placed into two groups (US exposure group and control group) and the array (ISPTP = 100 mW/cm2) with a saline reservoir operating for 20 min was affixed to the abdomen. The array was removed and an electrochemical glucose sensor was placed on the exposed area to determine the glucose concentrations through the skin. Comparison was made using a commercial glucose meter with the blood collected from a jugular vein. The average blood glucose level determined by the sensor was 356.0 ± 116.6 mg/dl, and the glucose level measured by the commercial glucose meter was 424.8 ± 59.1 mg/dl. These results supported the use of this novel system consisting of the electrochemical glucose sensor and the cymbal array for glucose monitoring.

UR - http://www.scopus.com/inward/record.url?scp=20444438224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20444438224&partnerID=8YFLogxK

U2 - 10.1016/j.ultrasmedbio.2005.04.004

DO - 10.1016/j.ultrasmedbio.2005.04.004

M3 - Article

C2 - 15972203

AN - SCOPUS:20444438224

VL - 31

SP - 971

EP - 977

JO - Ultrasound in Medicine and Biology

JF - Ultrasound in Medicine and Biology

SN - 0301-5629

IS - 7

ER -